Creon and Imitrex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Creon (pancrelipase (amylase;lipase;protease)) and Imitrex (sumatriptan succinate). Common drug interactions include malaise among females and chest pain among males.

The phase IV clinical study analyzes what interactions people have when they take Creon and Imitrex. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Creon?

Creon has active ingredients of pancrelipase (amylase;lipase;protease). It is often used in pancreatitis. eHealthMe is studying from 29,489 Creon users. Check the latest studies of Creon.

What is Imitrex?

Imitrex has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 17,149 Imitrex users. Check the latest studies of Imitrex.



On Aug, 08, 2026

14 people who take Creon and Imitrex together, and have interactions are studied.

Creon and Imitrex drug interactions.

What are the common drug interactions of Creon and Imitrex, by gender? *:

female:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Nausea (feeling of having an urge to vomit)
  3. Abdominal pain upper
  4. Abdominal pain
  5. Asthenia (weakness)
  6. Blood amylase increased
  7. Hypophagia (reduced food intake)
  8. Lower respiratory tract infection
  9. Memory impairment
  10. Vomiting projectile

male:

  1. Chest pain
  2. Headache (pain in head)
  3. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  4. Night sweats (sweating in night)
  5. Productive cough
  6. Pruritus (severe itching of the skin)
  7. Pseudomonas test positive
  8. Pyrexia (fever)
  9. Secretion discharge
  10. Sputum discoloured

What are the common drug interactions of Creon and Imitrex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abdominal pain upper
  2. Dehydration (dryness resulting from the removal of water)
  3. Heart rate increased
  4. Nausea (feeling of having an urge to vomit)
  5. Vomiting

20-29:

  1. Headache (pain in head)
  2. Tremor (trembling or shaking movements in one or more parts of your body)

30-39:

  1. Asthenia (weakness)
  2. Chest discomfort
  3. Chest pain
  4. Cough
  5. Decreased appetite
  6. Diarrhoea
  7. Dyspnoea (difficult or laboured respiration)
  8. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  9. Headache (pain in head)
  10. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)

40-49:

  1. Flushing (the warm, red condition of human skin)
  2. Gastric disorder (disease of stomach)
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Headache (pain in head)
  5. Hemiparesis (weakness on one side of the body)
  6. Hot flush (sudden feelings of heat)
  7. Influenza
  8. Insomnia (sleeplessness)
  9. Nausea (feeling of having an urge to vomit)
  10. Non-cardiac chest pain

50-59:

  1. Abdominal discomfort
  2. Abdominal pain lower
  3. Back pain
  4. Chest pain
  5. Drug effect decreased
  6. Muscle strain (an injury to a muscle in which the muscle fibres tear)
  7. Rectal haemorrhage (bleeding from anus)

60+:

n/a

What are the existing conditions these people have? *

  1. Pain: 6 people, 42.86%
  2. Cystic Fibrosis (disease of the secretary glands): 4 people, 28.57%
  3. Indigestion: 3 people, 21.43%
  4. Osteoporosis (bones weak and more likely to break): 3 people, 21.43%
  5. Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 3 people, 21.43%
  6. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 14.29%
  7. Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 14.29%
  8. Migraine Without Aura (headache without neurological problems): 2 people, 14.29%
  9. Impaired Gastric Emptying: 2 people, 14.29%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Creon and Imitrex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Creon and Imitrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Creon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Imitrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Creon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Imitrex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pancrelipase (amylase;lipase;protease) and sumatriptan succinate (the active ingredients of Creon and Imitrex, respectively), and Creon and Imitrex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: